Increased isolevuglandin-modified proteins in glaucomatous astrocytes

Bharathi Govindarajan, Anna Junk, Mabel Algeciras, Robert G. Salomon, Sanjoy K Bhattacharya

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purpose: Lipid oxidation has been proposed to be a factor in the pathophysiology of glaucoma. We investigated whether elevated levels of isolevuglandin (iso[4]LGE2) protein adducts are associated with astrocytes derived from the glaucomatous optic nerve head. In addition, we examined whether the iso[4]LGE2 protein adducts are altered following exposure of astrocytes to elevated pressure. Methods: Astrocytes were isolated from rat brain cortex and human optic nerve and were subjected to pressure treatments, western blot analyses, liquid chromatography tandem mass spectrometry, and immunocytochemistry. Results: Elevated levels of isolevuglandin (iso[4]LGE2) protein adducts were associated with astrocytes derived from the glaucomatous (n=10) optic nerve head when compared to those from controls (n=6). Astrocytes subjected to in vitro pressure treatment resulted in increased levels of iso[4]LGE2 protein adducts. Pressure exposure and the recovery period affect iso[4]LGE2 protein modification, and pyridoxamine was effective in decreasing the appearance of iso[4]LGE2 protein adduct immunoreactivity when applied immediately after pressure treatment. Conclusions: These results suggest that the elevated iso[4]LGE2 protein adduct immunoreactivity observed in glaucomatous astrocytes may be due to chronic and/or prolonged exposure to pressure, and pyridoxamine may have prophylactic utility against such oxidative protein modification.

Original languageEnglish
Pages (from-to)1079-1091
Number of pages13
JournalMolecular Vision
Volume15
StatePublished - Jun 1 2009

Fingerprint

Astrocytes
Pressure
Proteins
Pyridoxamine
Optic Disk
Optic Nerve
Tandem Mass Spectrometry
iso(4)levuglandin E2
Liquid Chromatography
Glaucoma
Therapeutics
Western Blotting
Immunohistochemistry
Lipids
Brain

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Increased isolevuglandin-modified proteins in glaucomatous astrocytes. / Govindarajan, Bharathi; Junk, Anna; Algeciras, Mabel; Salomon, Robert G.; Bhattacharya, Sanjoy K.

In: Molecular Vision, Vol. 15, 01.06.2009, p. 1079-1091.

Research output: Contribution to journalArticle

Govindarajan, B, Junk, A, Algeciras, M, Salomon, RG & Bhattacharya, SK 2009, 'Increased isolevuglandin-modified proteins in glaucomatous astrocytes', Molecular Vision, vol. 15, pp. 1079-1091.
Govindarajan, Bharathi ; Junk, Anna ; Algeciras, Mabel ; Salomon, Robert G. ; Bhattacharya, Sanjoy K. / Increased isolevuglandin-modified proteins in glaucomatous astrocytes. In: Molecular Vision. 2009 ; Vol. 15. pp. 1079-1091.
@article{c51d17b293374518b5406908fb31e4c1,
title = "Increased isolevuglandin-modified proteins in glaucomatous astrocytes",
abstract = "Purpose: Lipid oxidation has been proposed to be a factor in the pathophysiology of glaucoma. We investigated whether elevated levels of isolevuglandin (iso[4]LGE2) protein adducts are associated with astrocytes derived from the glaucomatous optic nerve head. In addition, we examined whether the iso[4]LGE2 protein adducts are altered following exposure of astrocytes to elevated pressure. Methods: Astrocytes were isolated from rat brain cortex and human optic nerve and were subjected to pressure treatments, western blot analyses, liquid chromatography tandem mass spectrometry, and immunocytochemistry. Results: Elevated levels of isolevuglandin (iso[4]LGE2) protein adducts were associated with astrocytes derived from the glaucomatous (n=10) optic nerve head when compared to those from controls (n=6). Astrocytes subjected to in vitro pressure treatment resulted in increased levels of iso[4]LGE2 protein adducts. Pressure exposure and the recovery period affect iso[4]LGE2 protein modification, and pyridoxamine was effective in decreasing the appearance of iso[4]LGE2 protein adduct immunoreactivity when applied immediately after pressure treatment. Conclusions: These results suggest that the elevated iso[4]LGE2 protein adduct immunoreactivity observed in glaucomatous astrocytes may be due to chronic and/or prolonged exposure to pressure, and pyridoxamine may have prophylactic utility against such oxidative protein modification.",
author = "Bharathi Govindarajan and Anna Junk and Mabel Algeciras and Salomon, {Robert G.} and Bhattacharya, {Sanjoy K}",
year = "2009",
month = "6",
day = "1",
language = "English",
volume = "15",
pages = "1079--1091",
journal = "Molecular Vision",
issn = "1090-0535",

}

TY - JOUR

T1 - Increased isolevuglandin-modified proteins in glaucomatous astrocytes

AU - Govindarajan, Bharathi

AU - Junk, Anna

AU - Algeciras, Mabel

AU - Salomon, Robert G.

AU - Bhattacharya, Sanjoy K

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Purpose: Lipid oxidation has been proposed to be a factor in the pathophysiology of glaucoma. We investigated whether elevated levels of isolevuglandin (iso[4]LGE2) protein adducts are associated with astrocytes derived from the glaucomatous optic nerve head. In addition, we examined whether the iso[4]LGE2 protein adducts are altered following exposure of astrocytes to elevated pressure. Methods: Astrocytes were isolated from rat brain cortex and human optic nerve and were subjected to pressure treatments, western blot analyses, liquid chromatography tandem mass spectrometry, and immunocytochemistry. Results: Elevated levels of isolevuglandin (iso[4]LGE2) protein adducts were associated with astrocytes derived from the glaucomatous (n=10) optic nerve head when compared to those from controls (n=6). Astrocytes subjected to in vitro pressure treatment resulted in increased levels of iso[4]LGE2 protein adducts. Pressure exposure and the recovery period affect iso[4]LGE2 protein modification, and pyridoxamine was effective in decreasing the appearance of iso[4]LGE2 protein adduct immunoreactivity when applied immediately after pressure treatment. Conclusions: These results suggest that the elevated iso[4]LGE2 protein adduct immunoreactivity observed in glaucomatous astrocytes may be due to chronic and/or prolonged exposure to pressure, and pyridoxamine may have prophylactic utility against such oxidative protein modification.

AB - Purpose: Lipid oxidation has been proposed to be a factor in the pathophysiology of glaucoma. We investigated whether elevated levels of isolevuglandin (iso[4]LGE2) protein adducts are associated with astrocytes derived from the glaucomatous optic nerve head. In addition, we examined whether the iso[4]LGE2 protein adducts are altered following exposure of astrocytes to elevated pressure. Methods: Astrocytes were isolated from rat brain cortex and human optic nerve and were subjected to pressure treatments, western blot analyses, liquid chromatography tandem mass spectrometry, and immunocytochemistry. Results: Elevated levels of isolevuglandin (iso[4]LGE2) protein adducts were associated with astrocytes derived from the glaucomatous (n=10) optic nerve head when compared to those from controls (n=6). Astrocytes subjected to in vitro pressure treatment resulted in increased levels of iso[4]LGE2 protein adducts. Pressure exposure and the recovery period affect iso[4]LGE2 protein modification, and pyridoxamine was effective in decreasing the appearance of iso[4]LGE2 protein adduct immunoreactivity when applied immediately after pressure treatment. Conclusions: These results suggest that the elevated iso[4]LGE2 protein adduct immunoreactivity observed in glaucomatous astrocytes may be due to chronic and/or prolonged exposure to pressure, and pyridoxamine may have prophylactic utility against such oxidative protein modification.

UR - http://www.scopus.com/inward/record.url?scp=66649117159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66649117159&partnerID=8YFLogxK

M3 - Article

C2 - 19503745

AN - SCOPUS:66649117159

VL - 15

SP - 1079

EP - 1091

JO - Molecular Vision

JF - Molecular Vision

SN - 1090-0535

ER -